Polycystic ovary syndrome and cardiovascular disease: a premature association?

Cited by (465)

Items 101–200 of 465

1. Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature
   Thomson, R. L., Buckley, J. D., Brinkworth, G. D. · 2011 · Obesity Reviews
2. Cadmium and Reproductive Health in Women: A Systematic Review of the Epidemiologic Evidence
   Anna Z. Pollack, Shamika Ranasinghe, Lindsey A. Sjaarda, Sunni L. Mumford · 2014 · Current Environmental Health Reports
3. The effects of metformin on metabolic and cardiovascular risk factors in nonobese women with polycystic ovary syndrome
   Yılmaz Şahin, Kürşad Ünlühızarcı, Ayse Yilmazsoy, Ali Yıkılmaz, Ercan Aygen, Fahrettin Keleştimur · 2007 · Clinical Endocrinology
4. Is interleukin-18 associated with polycystic ovary syndrome?
   Yang Yan, Jie Qiao, Rong Li, Meizhi Li · 2011 · Reproductive Biology and Endocrinology
5. Effects of metformin plus simvastatin on polycystic ovary syndrome: a prospective, randomized, double-blind, placebo-controlled study
   Talieh Kazerooni, Azam Shojaei-Baghini, Sedigheh Dehbashi, Nasrin Asadi, Fariborz Ghaffarpasand, Yasaman Kazerooni · 2010 · Fertility and Sterility
6. Long-Cycle Treatment with Oral Contraceptives
   Inka Wiegratz, Herbert Kühl · 2004 · Drugs
7. Comparative Analysis of Machine Learning Algorithms in Diagnosis of Polycystic Ovarian Syndrome
   Malik Mubasher Hassan, Tabasum Mirza · 2020 · International Journal of Computer Applications
8. Obese But Not Normal-Weight Women with Polycystic Ovary Syndrome Are Characterized by Metabolic and Microvascular Insulin Resistance
   Iris J. G. Ketel, Coen D.A. Stehouwer, Erik H. Serné, Ted J. M. Korsen, Peter G.A. Hompes, Yvo Michiel Smulders, Renate T. de Jongh, Roy Homburg, Cornelis Bavo Lambalk · 2008 · The Journal of Clinical Endocrinology & Metabolism
9. Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome
   Bee Kang Tan, J. Chen, Janet E. Digby, S.D. Keay, C. Richard Kennedy, Harpal Singh Randeva · 2006 · Diabetologia
10. Prevention of diabetes and cardiovascular disease in women with PCOS: Treatment with insulin sensitizers
    Susmeeta T. Sharma, John E. Nestler · 2006 · Best Practice & Research Clinical Endocrinology & Metabolism
11. Polycystic ovarian syndrome and subclinical atherosclerosis among women of reproductive age in the Dallas heart study
    Alice Y. Chang, Colby R. Ayers, Abu Minhajuddin, Tulika Jain, Pamela Nurenberg, James A. de Lemos, Robert A. Wild, Richard Joseph Auchus · 2010 · Clinical Endocrinology
12. The Effects of Flaxseed Oil Omega-3 Fatty Acids Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
    Golara Mirmasoumi, Mohammad Fazilati, Fatemeh Foroozanfard, Zahra Vahedpoor, Samaneh Mahmoodi, Mohsen Taghizadeh, Nazanin Kazemi Esfeh, Maryam Mohseni, Hassan Karbassizadeh, Zatollah Asemi · 2017 · Experimental and Clinical Endocrinology & Diabetes
13. Polycystic ovary syndrome and its impact on women’s quality of life: More than just an endocrine disorder
    Shaker Mousa, Brady, Shaker Mousa, Mousa · 2009 · Drug Healthcare and Patient Safety
14. Melatonin and its correlation with testosterone in polycystic ovarian syndrome
    Jain, Madhu, Jain, Priyanka, Haldar, Chandana, Singh, TejBali, Jain, Shuchi · 2013 · Journal of Human Reproductive Sciences
15. Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking
    Manuel Luque‐Ramírez, Covandonga Mendieta-Azcona, José M. del Rey Sánchez, M. Maties, Héctor Francisco Escobar-Morreale · 2009 · European Journal of Endocrinology
16. Periodontal Status and High‐Sensitivity C‐Reactive Protein Levels in Polycystic Ovary Syndrome With and Without Medical Treatment
    Surya Porwal, Shikha Tewari, Rajinder Kumar Sharma, Savita Rani Singhal, Satish Chander Narula · 2014 · Journal of Periodontology
17. Long-term consequences of polycystic ovary syndrome on cardiovascular risk
    Manfredi Rizzo, Kaspar K. Berneis, Giatgen A. Spinas, Giovam Battista Rini, Enrico Carmina · 2008 · Fertility and Sterility
18. Polycystic Ovary Syndrome in the Adolescent
    Samantha M. Pfeifer, Sari Leanne Kives · 2009 · Obstetrics and Gynecology Clinics of North America
19. Insulin-sensitizing agents: use in pregnancy and as therapy in polycystic ovary syndrome
    Miguel Ángel Checa, A. Requena, Cristina Salvador, Rosa Tur, J. Callejo, Juan José Espinós, Francisco Fábregues, Judith Cacho Herrero, (Reproductive Endocrinology Interest Group of the Spanish Society of Fertility) · 2005 · Human Reproduction Update
20. Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with Troglitazone
    Richard S. Legro, Ricardo Azziz, David A. Ehrmann, Anita Gmerek Fereshetian, Mary O’Keefe, Mahmoud N. Ghazzi · 2003 · The Journal of Clinical Endocrinology & Metabolism
21. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome
    Rebecca Louise Thomson, Jonathan David Buckley, Lisa Moran, Manny Noakes, Peter Marshall Clifton, Robert John Norman, Grant David Brinkworth · 2009 · BJOG An International Journal of Obstetrics & Gynaecology
22. High prevalence of metabolic syndrome among young women with premature coronary artery disease
    Hasan Turhan, Ayşe Saatçı Yaşar, Nurcan Başar, Asuman Biçer, Ali Rıza Erbay, Ertan Yetkın · 2005 · Coronary Artery Disease
23. Insulin resistance in patients with polycystic ovary syndrome
    Annika K. Schröder, S. Tauchert, Olaf Ortmann, Klaus Diedrich, Jürgen Michael Weiss · 2004 · Annals of Medicine
24. Metabolic syndrome and its components among women with polycystic ovary syndrome: a systematic review and meta-analysis
    Jamal Hallajzadeh, Maliheh Khoramdad, Nahid Karamzad, Amir Almasi‐Hashiani, Ali Janati, Erfan Ayubi, Reza Pakzad, Mark J. M. Sullman, Saeid Safiri · 2018 · Journal of Cardiovascular and Thoracic Research
25. An Efficient Decision Tree Establishment and Performance Analysis with Different Machine Learning Approaches on Polycystic Ovary Syndrome
    Aroni Saha Prapty, Tanzim Tamanna Shitu · 2020 · International Conference on Computer and Information Technology (ICCIT)
26. Greater Arterial Stiffness in Polycystic Ovary Syndrome (PCOS) Is an Obesity- But Not a PCOS-Associated Phenomenon
    Iris J. G. Ketel, Coen D.A. Stehouwer, Ronald M.A. Henry, Erik H. Serné, Peter G.A. Hompes, Roy Homburg, Yvo Michiel Smulders, Cornelis Bavo Lambalk · 2010 · The Journal of Clinical Endocrinology & Metabolism
27. Body fat and insulin resistance independently predict increased serum C-reactive protein in hyperandrogenic women with polycystic ovary syndrome
    Flavia Tosi, Romolo Marco Dorizzi, Roberto Castello, Claudio Maffeis, Giovanna Spiazzi, Giacomo Zoppini, Michele Muggeo, Paolo Moghetti · 2009 · European Journal of Endocrinology
28. Vascular Risk in Young Women With Polycystic Ovary and Polycystic Ovary Syndrome
    Cesare Battaglia, Fulvia Mancini, Arianna Cianciosi, Paolo Busacchi, Fabio Facchinetti, Giulio Marchesini, Rebecca Marzocchi, Domenico De Aloysio · 2008 · Obstetrics and Gynecology
29. Association of +45G15G(T/G) and +276(G/T) polymorphisms in the ADIPOQ gene with polycystic ovary syndrome among Han Chinese women
    Ning Zhang, Yuhua Shi, Cuifang Hao, Harvest Feng Gu, Yuan Li, Yueran Zhao, Laicheng Wang, Zi‐Jiang Chen · 2008 · European Journal of Endocrinology
30. Transgender Primary Medical Care
    Jamie Feldman, Joshua M. Goldberg · 2006 · International Journal of Transgenderism
31. Early Biomarkers of Subclinical Atherosclerosis in Obese Adolescent Girls with Polycystic Ovary Syndrome
    Kara S. Hughan, Hala Mounir Tfayli, Julia Warren-Ulanch, Emma Barinas‐Mitchell, Silva A Arslanian · 2015 · The Journal of Pediatrics
32. Flow‐mediated dilatation in overweight and obese women with polycystic ovary syndrome
    Grant David Brinkworth, Manny Noakes, Lisa Moran, Robert John Norman, Peter Marshall Clifton · 2006 · BJOG An International Journal of Obstetrics & Gynaecology
33. Use of metformin in the treatment of polycystic ovary syndrome
    Genazzani, Alessandro D, Ricchieri, Federica, Lanzoni, Chiara · 2010 · Women's Health
34. Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study
    Cesare Battaglia, Fulvia Mancini, Raffaella Fabbri, Nicola Persico, Paolo Busacchi, Fabio Facchinetti, Stefano Venturoli · 2009 · Fertility and Sterility
35. Metabolomics Reveals Reduction of Metabolic Oxidation in Women with Polycystic Ovary Syndrome after Pioglitazone-Flutamide-Metformin Polytherapy
    María Vinaixa, Miguel Angel Rodriguez, Sara Samino, Marta Díaz, Antoni Beltran, Roger Mallol, Cinta Bladé, Lourdes Ibáñez, Xavier Correig, Óscar Yanes · 2011 · PLoS ONE
36. Present status of understanding on the genetic etiology of polycystic ovary syndrome
    Shilpi Dasgupta, Mohan B Reddy · 2008 · Journal of Postgraduate Medicine
37. Polycystic ovary syndrome and its multidimensional impacts on women’s mental health: A narrative review
    Haya Almhmoud, Lara Alatassi, Mouna Baddoura, Joudy Sandouk, Mohamad Zafer Alkayali, Hasan Najjar, Basem Zaino · 2024 · Medicine
38. Testosterone as a Modulator of Vascular Behavior
    Marguerite T. Littleton‐Kearney, Patricia D. Hurn · 2004 · Biological Research For Nursing
39. Reproductive Health as a Sentinel of Chronic Disease in Women
    Janet Wilson Rich-Edwards · 2009 · Women s Health
40. Subclinical atherosclerosis and hyperandrogenemia are independent risk factors for increased epicardial fat thickness in patients with PCOS and idiopathic hirsutism
    Evrim Çakır, Mehmet Doğan, Oya Topaloğlu, Mustafa Özbek, Erman Çakal, Mustafa Gökhan Vural, Ekrem Yeter, Tuncay Delibaşı · 2012 · Atherosclerosis
41. Afamin serum concentrations are associated with insulin resistance and metabolic syndrome in polycystic ovary syndrome
    Beata Seeber, Elisabeth Morandell, Fabian Lunger, L. Wildt, Hans Dieplinger · 2014 · Reproductive Biology and Endocrinology
42. Polycystic Ovary Syndrome and the Metabolic Syndrome
    Julie L. Sharpless · 2003 · Clinical Diabetes
43. Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin
    Manuel Luque‐Ramírez, F. Alvarez-Blasco, M. G. Uriol Rivera, Héctor Francisco Escobar-Morreale · 2008 · Human Reproduction
44. Genomic variants in polycystic ovary syndrome
    Manuel Luque‐Ramírez, José L. San Millán, Héctor Francisco Escobar-Morreale · 2005 · Clinica Chimica Acta
45. Metformin improves endothelial function in normoinsulinemic PCOS patients: a new prospective
    Daniela Romualdi, Barbara Costantini, L. Selvaggi, Maddalena Giuliani, Francesca Cristello, F. Macrì, Alessandro Bompiani, Antonio Lanzone, Maurizio Guido · 2008 · Human Reproduction
46. Endocrine Disruptors, Obesity, and Cytokines - How Relevant Are They to PCOS?
    Markéta Šimková, Jana Vítků, Lucie Kolátorová, Jana Vrbíková, Michala Vosátková, Josef Včelák, Michaela Dušková · 2020 · Physiological Research
47. Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome
    Manuel Luque‐Ramírez, Covadonga Mendieta-Azcona, Francisco Álvarez‐Blasco, Héctor Francisco Escobar-Morreale · 2008 · Fertility and Sterility
48. Clinical significance of ADAMTS1, ADAMTS5, ADAMTS9 aggrecanases and IL-17A, IL-23, IL-33 cytokines in polycystic ovary syndrome
    Melia Karaköse, Kadir Demircan, Esra Tutal, Taner Demirci, Mustafa Arslan, Mustafa Şahi̇n, H. T. Celik, Fatmanur Hacıevliyagil Kazancı, Jale Karakaya, Erman Çakal et al. · 2016 · Journal of Endocrinological Investigation
49. Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome
    Katie Nitsche, David A. Ehrmann · 2010 · Best Practice & Research Clinical Endocrinology & Metabolism
50. Androgens and Insulin – Two Key Players in Polycystic Ovary Syndrome
    Andreas N. Schüring, Nicole Schulte, Barbara Sonntag, Ludwig Kiesel · 2008 · Gyn�kologisch-geburtshilfliche Rundschau
51. Insulin resistance and the long-term consequences of polycystic ovary syndrome
    R. K. Bhathena · 2011 · Journal of Obstetrics and Gynaecology
52. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles
    Jabbour, Rhea, Ott, Johannes, Eppel, Wolfgang, Frigo, Peter · 2020 · PLOS ONE
53. Endothelial function and its relationship to leptin, homocysteine, and insulin resistance in lean and overweight eumenorrheic women and PCOS patients: a pilot study
    Fulvia Mancini, Arianna Cianciosi, Giulio Marchesini, Fabio Facchinetti, Cesare Battaglia, Domenico De Aloysio · 2008 · Fertility and Sterility
54. Impaired uterine perfusion associated with metabolic disorders in women with polycystic ovary syndrome
    Chebib Chekir, Mikiya Nakatsuka, Yasuhiko Kamada, Soichi Noguchi, Aiko Sasaki, Yuji Hiramatsu · 2005 · Acta Obstetricia Et Gynecologica Scandinavica
55. Polycystic Ovary Syndrome
    Minisha Sood, Susan B. Zweig, Marsha C. Tolentino, Marina Strizhevsky, Leonid Poretsky · 2017 · Springer eBooks
56. Endothelial Function Varies According to Insulin Resistance Disease Type
    Joshua A. Beckman, Allison B. Goldfine, Andrea Elizabeth Dunaif, Marie Denise Gerhard‐Herman, Mark A. Creager · 2007 · Diabetes Care
57. Visfatin and retinol-binding protein 4 concentrations in lean, glucose-tolerant women with PCOS
    Bülent Okan Yıldız, Gürkan Bozdağ, Umit Otegen, Ayla Harmancı, K. Boynukalin, Zehra Vural, Şerafettin Kirazlı, Hakan Yaralı́ · 2009 · Reproductive BioMedicine Online
58. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-γ gene in women with polycystic ovary syndrome
    Murat Yılmaz, Mehmet Ali Ergün, Ayhan Karakoç, Erkan Yurtçu, Nuri Çakır, Metin Arslan · 2006 · Gynecological Endocrinology
59. Surrogate end-points or primary outcomes in clinical trials in women with polycystic ovary syndrome?
    Richard S. Legro · 2004 · Human Reproduction
60. Cardiovascular complications of obesity in adolescents
    Francesco Orio, Stefano Palomba, Teresa Cascella, Silvia Savastano, Gaetano Lombardi, Annamaria Anita Livia Colao · 2007 · Journal of Endocrinological Investigation
61. Continuation of Metformin Reduces Early Pregnancy Loss in Obese Pakistani Women with Polycystic Ovarian Syndrome
    Fauzia Haq Nawaz, Javed Rizvi · 2009 · Gynecologic and Obstetric Investigation
62. Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study
    Saika Manzoor, Mohd Ashraf Ganie, Shajrul Amin, Zafar A. Shah, Imtiyaz Ahmad Bhat, Syed Douhath Yousuf, Humira Jeelani, Iram Ashaq Kawa, Qudsia Fatima, Fouzia Rashid · 2019 · Scientific Reports
63. Polycystic ovary syndrome dependency on mtDNA mutation; copy Number and its association with insulin resistance
    Noor Al-Huda Ali A.H. Saeed, Israa Hussein Hamzah, Samar Abdul Raheem Al-Gharrawi · 2019 · BMC Research Notes
64. Menstrual Health and the Metabolic Syndrome in Adolescents
    Hala Mounir Tfayli, Silva A Arslanian · 2008 · Annals of the New York Academy of Sciences
65. Chromium Supplementation and the Effects on Metabolic Status in Women with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
    Jamilian, Mehri, Asemi, Zatollah · 2015 · Annals of Nutrition and Metabolism
66. MTHFR C677T polymorphism is associated with hyperlipidemia in women with polycystic ovary syndrome
    Madhu Jain, Priyanka Pandey, Narendra Kumar Tiwary, Shuchi M. Jain · 2012 · Journal of Human Reproductive Sciences
67. Diagnosis and Treatment of Polycystic Ovary Syndrome
    Hyejin Lee, Yeon‐Ah Sung · 2007 · Journal of Korean Endocrine Society
68. Role of Haptoglobin in Polycystic Ovary Syndrome (PCOS), Obesity and Disorders of Glucose Tolerance in Premenopausal Women
    Francisco Álvarez‐Blasco, María Ángeles Martínez-García, Manuel Luque‐Ramírez, Naiara Parraza, José L. San Millán, Héctor Francisco Escobar-Morreale · 2009 · PLoS ONE
69. Genetic Basis of Metabolic Abnormalities in Polycystic Ovary Syndrome
    Bel??n Rold??n, Jos L San Mill n, Héctor Francisco Escobar-Morreale · 2004 · American Journal of PharmacoGenomics
70. Second World Congress on the Insulin Resistance Syndrome
    Zachary T. Bloomgarden · 2005 · Diabetes Care
71. The Effects of Selenium Supplementation on Gene Expression Related to Insulin and Lipid in Infertile Polycystic Ovary Syndrome Women Candidate for In Vitro Fertilization: a Randomized, Double-Blind, Placebo-Controlled Trial
    Shahrzad Zadeh Modarres, Zahra Heidar, Fatemeh Foroozanfard, Zahra Rahmati, Esmat Aghadavod, Zatollah Asemi · 2017 · Biological Trace Element Research
72. Sustainability of 8% weight loss, reduction of insulin resistance, and amelioration of atherogenic-metabolic risk factors over 4 years by metformin-diet in women with polycystic ovary syndrome
    Charles J. Glueck, Dawit Aregawi, Mahlia Agloria, Magdalena Winiarska, Luann Sieve, Ping Wang · 2006 · Metabolism
73. Evolutionary determinants of polycystic ovary syndrome: part 1
    Uğur Ünlütürk, Efe Sezgın, Bülent Okan Yıldız · 2016 · Fertility and Sterility
74. Metabolic syndrome and cardiometabolic risk in PCOS
    Andrea J. Cussons, Bronwyn G. A. Stuckey, Gerald Francis Watts · 2007 · Current Diabetes Reports
75. Association of IRS-1 and IRS-2 genes polymorphisms with polycystic ovary syndrome: a meta-analysis
    Yuan Ruan, Jianhua Ma, Xiaojing Xie · 2012 · Endocrine Journal
76. The Effects of Calcium, Vitamins D and K co-Supplementation on Markers of Insulin Metabolism and Lipid Profiles in Vitamin D-Deficient Women with Polycystic Ovary Syndrome
    Karamali, Maryam, Ashrafi, Mahnaz, Razavi, Maryamalsadat, Jamilian, Mehri, Akbari, Maryam, Asemi, Zatollah · 2017 · Experimental and Clinical Endocrinology & Diabetes
77. Targeting insulin sensitivity in the treatment of polycystic ovary syndrome
    Renato Pasquali, Alessandra Gambineri · 2009 · Expert Opinion on Therapeutic Targets
78. Polycystic ovary syndrome and periodontal disease: Underlying links- A review
    Sri Chandana Tanguturi, Sreenivas Nagarakanti · 2018 · Indian Journal of Endocrinology and Metabolism
79. Cardiovascular risk in normal weight, eumenorrheic, nonhirsute daughters of patients with polycystic ovary syndrome: a pilot study
    Cesare Battaglia, Fulvia Mancini, Arianna Cianciosi, Paolo Busacchi, Nicola Persico, Roberto Paradisi, Fabio Facchinetti, Domenico De Aloysio · 2008 · Fertility and Sterility
80. Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome
    Karbek, Basak, Ozbek, Mustafa, Karakose, Melia, Topaloglu, Oya, Bozkurt, Nujen, Cakır, Evrim, Aslan, Muyesser, Delibasi, Tuncay · 2014 · Journal of Ovarian Research
81. Increased arterial stiffness in mildly‐hypertensive women with polycystic ovary syndrome
    Aiko Sasaki, Yayoi Emi, 美和 松田, Sharula, Yasuhiko Kamada, Chebib Chekir, Yuji Hiramatsu, Mikiya Nakatsuka · 2011 · Journal of obstetrics and gynaecology research
82. Identification of the Active Constituents and Significant Pathways of Cangfu Daotan Decoction for the Treatment of PCOS Based on Network Pharmacology
    Wenting Xu, Mengyu Tang, Jiahui Wang, Lihong Wang · 2020 · Evidence-based Complementary and Alternative Medicine
83. Polycystic ovary syndrome in post-menopausal women—marker of the metabolic syndrome
    Elena Margolin, Taiba Zornitzki, Gideon Kopernik, Sofy Kogan, Ami Schattner, Hilla Knobler · 2004 · Maturitas
84. Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters
    Hüseyin Demirci, Murat Yılmaz, Mehmet Ali Ergün, Erkan Yurtçu, Neslihan Celik Bukan, Göksün Ayvaz · 2009 · Gynecological Endocrinology
85. Levels of Neopterin and other Inflammatory Markers in Obese and Non-Obese Patients with Polycystic Ovary Syndrome
    Talip Gul · 2015 · Medical Science Monitor
86. TNF-α haplotype association with polycystic ovary syndrome – a South Indian study
    M. Deepika, K. Ranjith Reddy, A. L. Yashwanth, V. Usha Rani, K. Prasanna Latha, Parveen Jahan · 2013 · Journal of Assisted Reproduction and Genetics
87. A 27-Year-Old Woman With a Diagnosis of Polycystic Ovary Syndrome
    Richard S. Legro · 2007 · JAMA
88. Risk of Cardiovascular Events in Mothers of Women with Polycystic Ovary Syndrome
    Cheang, Kai I., Nestler, John E., Futterweit, Walter · 2008 · Endocrine Practice
89. Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome
    Iliana Doycheva, David A. Ehrmann · 2022 · Fertility and Sterility
90. Effect of cadmium exposure during and after pregnancy of female
    Waseem Ali, Yusheng Bian, Hao Zhang, Izhar Hyder Qazi, Hui Zou, Jiaqiao Zhu, Zongping Liu · 2023 · Environmental Pollutants and Bioavailability
91. Prevalence of ultrasonography proved polycystic ovaries in North Indian women with type 2 diabetes mellitus
    Abdul Hamid Zargar, Vipin Gupta, Arshad Iqbal Wani, Shariq Rashid Masoodi, Mir Iftikhar Bashir, Bashir Ahmad Laway, Mohammad Ashraf Ganie, Mohammad Salahuddin · 2005 · Reproductive Biology and Endocrinology
92. Retracted article: The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial
    Mehrdad Amini, Fereshteh Bahmani, Fatemeh Foroozanfard, Zahra Vahedpoor, Amir Ghaderi, Mohsen Taghizadeh, Hassan Karbassizadeh, Zatollah Asemi · 2018 · Journal of Psychosomatic Obstetrics & Gynecology · Retracted
93. MicroRNA-21 inhibits ovarian granulosa cell proliferation by targeting SNHG7 in premature ovarian failure with polycystic ovary syndrome
    Fahad M. Aldakheel, Abdulwahab Abuderman, Shatha Ahmed Alduraywish, Yuhong Xiao, Wen Wang Guo · 2021 · Journal of Reproductive Immunology
94. Roles of Perilipins in Diseases and Cancers
    Pengpeng Zhang, Lian Meng, Lingxie Song, Juan Du, Shutong Du, Wenwen Cui, Chunxia Liu, Feng Li · 2017 · Current Genomics
95. Women with Polycystic Ovary Syndrome and Risk of Cardiovascular Disease
    Iva Perović-Blagojević, Tatjana Eror, Pelivanović Jovana, Svetlana Jelić, Jelena Kotur‐Stevuljević, Svetlana Ignjatović · 2017 · Journal of Medical Biochemistry
96. Impact of yoga and exercises on polycystic ovarian syndrome risk among adolescent schoolgirls in South India
    Valarmathi Selvaraj, Jain Vanitha, Fabiola M. Dhanaraj, Prema Sekar, Anitha Rajendra Babu · 2020 · Health Science Reports
97. Methylenetetrahydrofolate reductase C677T gene polymorphism in turkish patients with polycystic ovary syndrome
    Muammer Karadeniz, Mehmet Erdoğan, Ayhan Zengi, Zühal Eroğlu, Sadık Tamsel, Murat Olukman, Füsun Saygılı, Candeğer Yılmaz · 2010 · Endocrine
98. Hormone Therapy in Adults: Suggested Revisions to the Sixth Version of the Standards of Care
    Jamie Feldman, Joshua David Safer · 2009 · International Journal of Transgenderism
99. Síndrome dos ovários policísticos, síndrome metabólica, risco cardiovascular e o papel dos agentes sensibilizadores da insulina
    Regina do Carmo Silva, Dolores Pardini, Claudio Elias Kater · 2006 · Arquivos Brasileiros de Endocrinologia & Metabologia
100. Rosiglitazone treatment alleviates inflammation and improves liver function in overweight women with polycystic ovary syndrome: a randomized placebo-controlled study
     Katrina Rautio, Juha S. Tapanainen, Aimo Ruokonen, Laure C. Morin-Papunen · 2006 · Fertility and Sterility